| Author | : Heine Hansen |
| Publisher | : CRC Press |
| Release Date | : 2008-03-17 |
| ISBN 10 | : 9780415385107 |
| Pages | : 480 pages |
Textbook of Lung Cancer, 2nd edition, published in association with the European Society of Medical Oncology, is a comprehensive and multidisciplinary text, which examines all aspects of this disease, with contributions from a multinational team of authors on etiology, epidemiology, molecular biology, pathology, smoking, detection and management, clinical features, staging and prognostic factors, surgery, radiotherapy and chemotherapy. It provides essential information and guidance for specialist trainees in oncology, and for the many physicians and specialists involved in the field of lung cancer.
| Author | : Karen L. Reckamp |
| Publisher | : Springer |
| Release Date | : 2016-08-17 |
| ISBN 10 | : 3319403893 |
| Pages | : 322 pages |
This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice. The text opens with background and emerging information regarding the molecular biology of lung cancer pathogenesis. Updated results regarding lung cancer prevention and screening are discussed, followed by chapters on diagnostic techniques and pathological evaluation. This leads on to a detailed presentation of treatment modalities, from surgery and radiation therapy to standard chemotherapy and targeted agents. The coverage includes resistance to therapy and the emergence of immunotherapy for lung cancer; in addition, the current evidence in respect of small cell lung cancer is summarized. The book presents insights from experts across disciplines to emphasize the importance of collaborative care. Advances in our understanding of issues in geriatric oncology and palliative care complete the comprehensive discussion of lung cancer.
| Author | : Jürgen Heide,W. Hinkelbein,A. Schmittel,D. Kaiser |
| Publisher | : Karger Medical and Scientific Publishers |
| Release Date | : 2010 |
| ISBN 10 | : 3805592981 |
| Pages | : 211 pages |
Under the auspices of the 12th International Symposium on Special Aspects in Radiotherapy 2008 in Berlin, acknowledged experts presented their perspectives on small and non-small cell lung cancer, reflecting the latest standards and engaging in controversies in the diagnosis and treatment of this disease.In the first part of this volume, aspects of the diagnostic workup are highlighted from the histopathologist's point of view, followed by presentations concerning the value of PET-CT and whole-body MRI in the staging of lung cancer. The use and current methods in bronchoscopy, endoscopic ultrasound, video-endoscopy and mediastinoscopy are discussed in detail. The second section presents surgical and radio-oncological treatment concepts for stage I/II non-small cell lung cancer including stereotactic radiotherapy. The third section outlines the curative options for stage III NSCLC: extended surgical approaches , definitive radiochemotherapy and current concepts in adjuvant therapies. Emphasis is also placed on altered fractionation schemes in radiotherapy. Section 4 is dedicated to palliative procedures and the last section gives an in-depth presentation of small cell lung cancer.This book provides an excellent overview of up-to-date standards and future strategies in lung cancer treatment. It will be of great value to surgeons, radiation oncologists, pulmonary specialists and other clinicians interested in this disease.
| Author | : James D. Cox,Joe Y. Chang,Ritsuko Komaki |
| Publisher | : CRC Press |
| Release Date | : 2007-09-20 |
| ISBN 10 | : 9780849387821 |
| Pages | : 192 pages |
Lung cancer is the leading cause of cancer death in the United States, but IGRT (image guided radiation therapy) offers the possibility of more aggressive and enhanced treatments. The only available source on the subject that emphasizes new imaging techniques, and provides step-by-step treatment guidelines for lung cancer, this source helps clinicians locate and target tumors with enhanced speed, improve the accuracy of radiation delivery, and correctly target cancerous masses while avoiding surrounding structures. Edited by radiation oncology experts from the renowned M.D. Anderson Cancer Center, this guide: focuses on novel approaches using IGRT, particularly PET/CT, SPECT, 4-D CT, stereotactic body radiation therapy, IMRT and proton radiotherapy, and offers expert guidance on the dose, fractionation, target volume delineation (including recommended margins with and without respiratory gating based on our new 4-D CT study), and normal tissue tolerances stands as the first step-by-step guide for radiation oncologists to implement new image-guided techniques into their day-to-day clinical practice, and considers the practical issues of implementing these approaches into their routine helps clinicians use imaging technologies to detect changes in tumor size, shape, position, or metabolism over a course of radiotherapy treatment provides disease stage-specific treatment guidelines and clearly lays out imaging techniques serves as roadmap for future research and development
| Author | : Karen Parles,Joan H. Schiller,Amy Cipau |
| Publisher | : Jones & Bartlett Learning |
| Release Date | : 2012-05-16 |
| ISBN 10 | : 9781449630980 |
| Pages | : 239 pages |
EMPOWER YOURSELF! No one with lung cancer needs to be alone in their fight against this disease. 100 Questions & Answers About Lung Cancer, Second Edition enables patients and their families to seek out the best treatment possible for early detection of lung cancer. Providing both the doctor's and patient's point of view, this book is a complete guide to understanding treatment options, post-treatment quality of life, sources of support, and much more. Through 100 Questions & Answers About Lung Cancer, Second Edition, expert authors use their experiences with patients to provide support and hope to the tens of thousands of people coping with this disease.
| Author | : Karen L. Reckamp |
| Publisher | : Demos Medical Publishing |
| Release Date | : 2010-10-25 |
| ISBN 10 | : 1936287064 |
| Pages | : 368 pages |
Lung Cancer: Over the course of the last decade, the treatment of lung cancer has evolved quite rapidly. New scientific and clinical advances have modified the standard of care and led to improved patient outcomes. At the same time, the treatment of lung cancer has become increasingly complex, requiring the comprehensive review and assessment of multiple issues, genetics, radiology, surgery, reconstruction, chemotherapy, and more. As a result the harmony and open communication between these specialties facilitated by a multidisciplinary team approach are crucial in providing the best care to patients and ensuring successful treatment. Lung Cancer: A Multidisciplinary Approach to Diagnosis and Management, written by a multidisciplinary team of authors representing a range of disciplines, is a valuable resource for physicians, fellows, nurses, physician assistants, physical therapists, and all health care providers involved in the treatment of lung cancer. Lung Cancer: A Multidisciplinary Approach to Diagnosis and Management summarizes the state-of-the-art issues related to the treatment of lung cancer and describes an approach for optimal multidisciplinary care for individuals who have been diagnosed with lung cancer or who are at higher risk to develop lung cancer. About the Series: The Current Multidisciplinary Oncology series edited by Charles R. Thomas consolidates and integrates the varied aspects of multidisciplinary care for major topics in oncology, including breast, lung, prostrate, head and neck and more. The volumes in the Current Multidisciplinary Oncology series will represent all related topic areas, including oncology, radiation oncology, pain, pathology, imaging, psychological support and the primary disease. In addition, each volume includes a chapter focusing on special populations and the disease's impact / difference on them, and discussion of future directions and quality of life issues. In addition each volume has a chapter written by a private practice oncologist. All Current Multidisciplinary Oncology titles provide: Consolidation and integration of the varied aspects of multidisciplinary care for major topics in oncology Coverage of all related topic areas, including medical and surgical oncology, radiation oncology, pain, pathology, imaging, psychological support, and the primary disease A chapter focusing on special populations and the disease's impact / difference on them A chapter on community practice written by a private practice oncologist Discussion of quality-of-life issues
| Author | : Christopher John Hacon Williams |
| Publisher | : Oxford University Press, USA |
| Release Date | : 1992 |
| ISBN 10 | : 9780192622501 |
| Pages | : 148 pages |
Lung cancer is primarily a disease of well-developed affluent countries. It is by far the most common cancer in men, and is poised to overtake breast cancer as the most common cancer in women. Yet, although it is common, preventable, and sometimes curable, very little information isavailable about what happens when you get it - which is when accessible information is most needed.In a clear, non-emotive style, this revised and updated new edition provides the answers to the questions patients with lung cancers or those involved with them are likely to ask. The first section describes the causes (and includes a chapter on stopping smoking), diagnosis, and progression of thedisease. There follows a section on the curative and symptomatic treatments available for the different types of lung cancer; and the third section, new for this edition, discusses the future prospects for the disease and its treatment. Also included are a glossary, a list of further reading, andan extensive list of addresses of organizations which can provide help and advice.
| Author | : Fergus Macbeth,Robert Milroy,William Steward,Rod Burnett |
| Publisher | : CRC Press |
| Release Date | : 1996-12-01 |
| ISBN 10 | : 9780203091982 |
| Pages | : 329 pages |
"Lung Cancer: A Practical Guide to Management" is a straightforward introduction to this disease. It's aetiology, pathology and all aspects of routine management, as well as rarer conditions like bronchial carcinoid tumor and malignant mesothelioma, are covered clearly and concisely. It is based firmly on the author's own experience and management policies. Lung cancer is the most common cancer in men in the UK and is an increasingly common tumor in women. Most health professionals will therefore meet patients with this problem from time to time throughout their career.
| Author | : Jürgen Heide,W. Hinkelbein,A. Schmittel,D. Kaiser |
| Publisher | : Karger Medical and Scientific Publishers |
| Release Date | : 2010 |
| ISBN 10 | : 3805592981 |
| Pages | : 211 pages |
Under the auspices of the 12th International Symposium on Special Aspects in Radiotherapy 2008 in Berlin, acknowledged experts presented their perspectives on small and non-small cell lung cancer, reflecting the latest standards and engaging in controversies in the diagnosis and treatment of this disease.In the first part of this volume, aspects of the diagnostic workup are highlighted from the histopathologist's point of view, followed by presentations concerning the value of PET-CT and whole-body MRI in the staging of lung cancer. The use and current methods in bronchoscopy, endoscopic ultrasound, video-endoscopy and mediastinoscopy are discussed in detail. The second section presents surgical and radio-oncological treatment concepts for stage I/II non-small cell lung cancer including stereotactic radiotherapy. The third section outlines the curative options for stage III NSCLC: extended surgical approaches , definitive radiochemotherapy and current concepts in adjuvant therapies. Emphasis is also placed on altered fractionation schemes in radiotherapy. Section 4 is dedicated to palliative procedures and the last section gives an in-depth presentation of small cell lung cancer.This book provides an excellent overview of up-to-date standards and future strategies in lung cancer treatment. It will be of great value to surgeons, radiation oncologists, pulmonary specialists and other clinicians interested in this disease.
| Author | : Mary O'Brien,Benjamin Besse |
| Publisher | : Karger Medical and Scientific Publishers |
| Release Date | : 2016-08-22 |
| ISBN 10 | : 1910797197 |
| Pages | : 86 pages |
Rapid developments in the classification, screening and treatment of non-small-cell lung cancer (NSCLC) are improving outcomes for patients with the disease. This insightful guide is designed to bring you up to speed with recent advances, including: • the latest CT-based screening and interval growth imaging techniques • proposed changes to the TNM classification system • the increasing trend for minimally invasive and lung-sparing surgery • stereotactic radiation for early-stage tumors • new targeted therapies • breakthroughs in personalized medicine. Today's developments will change tomorrow's standards of care. 'Fast Facts: Non-Small-Cell Lung Cancer' is important reading for all health professionals and medical trainees working in this fast-moving area.
| Author | : Marilyn Haas |
| Publisher | : Jones & Bartlett Learning |
| Release Date | : 2010-10-25 |
| ISBN 10 | : 9780763760519 |
| Pages | : 364 pages |
"Contemporary Issues in Lung Cancer, Second Edition provides oncology nurses, students, and healthcare professionals with in-depth information on current issues that surround this disease while giving them the tools to impact both education and research. It addresses all aspects of the disease from incidence, risk factors, and the biology of lung cancer to the latest modes of treatment." --Book Jacket.
| Author | : Carmen Ferreiro,I. Edward Alcamo |
| Publisher | : Infobase Publishing |
| Release Date | : 2009-01-01 |
| ISBN 10 | : 1438101538 |
| Pages | : 329 pages |
Presents an overview of lung cancer, including a history of treatment and diagnosis, symptoms, and coping with the disease.
| Author | : Branislav Jeremic |
| Publisher | : Springer Science & Business Media |
| Release Date | : 2006-03-30 |
| ISBN 10 | : 3540266321 |
| Pages | : 526 pages |
Although decades of laboratory and clinical research have led to incremental improvement in treatment outcome, lung cancer remains one of the most deadly diseases. This volume is unique in being devoted solely to the radiation oncology of lung cancer, and will be of great value to all who are involved in the diagnosis and treatment of the disease. Both non-small cell and small cell lung cancer are considered in detail. Current state-of-the-art treatment strategies and novel approaches that promise further improvements in outcome are explained and evaluated, with the aid of high-quality illustrations. Treatment-related toxicity is discussed, and further individual chapters focus on topics such as quality of life studies, prognostic factors and pitfalls in the design and analysis of clinical trials.
| Author | : Barbara Driscoll |
| Publisher | : Springer Science & Business Media |
| Release Date | : 2003 |
| ISBN 10 | : 0896039854 |
| Pages | : 594 pages |
Leading physician scientists and noted researchers review novel methods for determining the etiology of a variety of lung cancers and present readily reproducible techniques for examining the associated multitude of genetic abnormalities. The methods make it possible to detect these alterations at the cellular, DNA, and protein levels, to study the development of lung cancer in vitro and in vivo-either in situ or in the form of metastases, and to test targeted therapies with detailed model systems. An animal models section gives explicit instructions for setting up and testing these systems, which are rarely described in the literature.
| Author | : Steven T. Rosen,James L. Mulshine |
| Publisher | : CRC Press |
| Release Date | : 1988-08-19 |
| ISBN 10 | : 9780824776428 |
| Pages | : 384 pages |
| Author | : Robert L. Carafaro |
| Publisher | : Nova Publishers |
| Release Date | : 2005 |
| ISBN 10 | : 9781594540820 |
| Pages | : 220 pages |
Lung cancer is the most common form of cancer in the world and a major cause of death. This new book brings together stellar research from around the world. The two main types of primary lung cancer small cell and non-small cell are examined. The book's scope encompasses the three main types of non-small cell lung cancer: squamous cell carcinoma which is the commonest type of lung cancer and develops in the cells which line the airways; adenocarcinoma develops from the cells which produce mucus in the lining of the airways; large cell carcinoma gets its name from the large, rounded cells that are seen when they are examined under the microscope. About 1 in 5 lung cancers are small cell, the rest non-small cell. Causes of lung cancer are primarily smoking, but include as well exposure to radon, asbestos, uranium, arsenic, and certain petroleum products. Research and new drugs are appearing with increasing frequency in this field.
| Author | : J. Gordon McVie,W. Bakker,Sj.Sc. Wagenaar,D. Carney |
| Publisher | : Springer Science & Business Media |
| Release Date | : 1986 |
| ISBN 10 | : 9780898387643 |
| Pages | : 188 pages |
J. G. MCVIE The impact of therapy on one subset of lung cancer, the "small cell" type has been significant and lasting. The reality of cure for even a fraction of patients with this disease has caused reverberations in the pathology lab where the responsibili. '~y and challenge of diagnosis of this vital sub group lies. No less dramatic has been the discovery that the cell types of lung cancer have recognisable growth characteristics in serum free culture, they are recognisable by patterns of markers and some produce growth factors which autoregulate their eventual fate. Many of the discoveries from the biological studies have impacted on the pathologist in the form of disturbing evidence for a single stem cell origin for all the cell types of lung cancer and in the shape of new facilitation in diagnosis by appli cation of immunoperoxidase techniques. Monoclonal antibodies raised against oncogene products, growth factor receptor sites, "bystander" cell membrane proteins can all be applied to cytology specimens and frozen or paraffin fixed tissue sections to aid diagnosis and some can be used in sequential serum assay to monitor therapy and predict prognosis. Adding to these extraordinary tools, the sophistication of electron micro scopy and immuno-electrcn microscopy, new techniques for preparation of tissue and novel methods for studying vital cells in "kinesis", you sense the flavour of the future of lung cancer which is captured in this book.
| Author | : Julie Walker |
| Publisher | : The Rosen Publishing Group |
| Release Date | : 2006 |
| ISBN 10 | : 9781404203884 |
| Pages | : 64 pages |
Discusses what lung cancer is and what causes it, symptoms it reveals and how it is diagnosed, and how it can be prevented and treated.
| Author | : David J. Stewart |
| Publisher | : Springer Science & Business Media |
| Release Date | : 2010-03-10 |
| ISBN 10 | : 9781607615248 |
| Pages | : 538 pages |
Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. It kills almost as many Americans as cancers of the breast, prostate, colon, rectum, pancreas, and 2 kidney combined, and accounts for 28.6% of all US cancer deaths. With an increase in the 5-year relative survival rate from 13% to only 16% in the more than 2 30 years from 1974 to the present, it will take us another 840 years to eradicate lung cancer deaths if we do not improve the current rate of progress. As discussed in this text, lung cancer prevention has received substantial att- tion. The decrease in smoking in recent decades has helped, but smoking is not the only problem. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States. Several factors contribute to the lethality of lung cancer, including the rapidity of tumor growth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as discussing our track record to date in exploiting them.
| Author | : Venkateshwar Keshamouni,Douglas Arenberg,Gregory Kalemkerian |
| Publisher | : Springer Science & Business Media |
| Release Date | : 2009-09-18 |
| ISBN 10 | : 1441907726 |
| Pages | : 409 pages |
Lung cancer is the leading cause of cancer-related mortality. Metastatic lung cancer is responsible for more than ninety percent of lung cancer related deaths. However, relatively little progress has been made in understanding the process of lung cancer metastasis. The two main aims of this book are a) to introduce clinical aspects to basic scientists and basic molecular and cellular concepts to clinical investigators, in order to promote collaboration and foster much needed translational research; and b) to introduce new and emerging concepts and approaches in metastasis research to lung cancer research community at large. In this attempt, the book will cover a broad spectrum of subjects ranging from the current trends in the clinical management of the metastatic disease, to the systems biology approach for gaining insights into the mechanisms of metastasis. Some of the subjects covered will include: defining basic hallmarks of a metastatic cell, the concept of tumor stem cells, epithelial-mesenchymal transitions, evasion of immune-surveillance, tumor-stromal interactions, angiogenesis, molecular imaging and biomarker discovery.